BOVITUBAL 28 000, injekcinė suspensija
BOVITUBAL 28 000, injekcinė suspensija
Authorised
- Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative
Product identification
Medicine name:
BOVITUBAL 28 000, injekcinė suspensija
Active substance:
- Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative
Target species:
-
Cattle
-
Sheep
-
Goat
-
Pig
-
Horse
-
Dog
Route of administration:
-
Intradermal use
Product details
Active substance and strength:
-
Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative28000.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV04CF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/94/0084/001-009
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV0084.pdf
Lithuanian (PDF)
Download Published on: 2/09/2022